Giuseppe Argenziano Selected Research

Cyclosporine (Ciclosporin)

1/2022	Letter in response to "Reply to: Topical cyclosporine 5% cream in Zoon's balanitis resistant to other therapies: A case report".
7/2021	Effectiveness and Safety of Long-Term Dupilumab Treatment in Elderly Patients with Atopic Dermatitis: A Multicenter Real-Life Observational Study.
1/2021	Topical cyclosporine 5% cream in Zoon's balanitis resistant to other therapies: A case report.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Giuseppe Argenziano Research Topics

Disease

31	Melanoma (Melanoma, Malignant) 05/2024 - 01/2003
24	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2024 - 11/2015
19	Neoplasms (Cancer) 03/2023 - 10/2006
12	Atopic Dermatitis (Atopic Eczema) 05/2024 - 11/2020
12	Basal Cell Carcinoma (Rodent Ulcer) 01/2023 - 02/2004
8	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2023 - 07/2012
8	Actinic Keratosis 12/2023 - 12/2012
7	Hidradenitis Suppurativa 07/2024 - 01/2021
5	Skin Neoplasms (Skin Cancer) 05/2024 - 12/2011
5	Skin Diseases (Skin Disease) 04/2024 - 02/2006
5	Neoplasm Metastasis (Metastasis) 03/2024 - 01/2022
5	Alopecia Areata 01/2024 - 11/2020
3	Alopecia (Baldness) 04/2023 - 01/2020
3	Lichen Planus (Lichen Ruber Planus) 04/2023 - 11/2015
3	Prurigo 01/2023 - 07/2020
3	Psoriatic Arthritis 05/2022 - 02/2021
3	COVID-19 01/2022 - 01/2021
2	Allergic Contact Dermatitis 04/2024 - 01/2022
2	Pain (Aches) 12/2023 - 03/2023
2	Molluscum Contagiosum 04/2023 - 02/2022
2	Infections 03/2023 - 01/2020
2	Mycosis Fungoides 02/2023 - 06/2010
2	Lymphoma (Lymphomas) 12/2022 - 01/2020
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 11/2022 - 03/2022
2	Nevus (Nevi) 11/2022 - 03/2017
2	Contact Dermatitis (Eczema, Contact) 01/2022 - 01/2006
2	Margins of Excision 01/2022 - 01/2013
2	Balanitis 01/2022 - 01/2021
2	Inflammation (Inflammations) 01/2022 - 01/2022
2	Eczema 07/2021 - 11/2015
2	Keratoacanthoma 08/2020 - 12/2012
2	Vitiligo 11/2019 - 11/2015
1	Delayed Hypersensitivity (Hypersensitivity, Type IV) 04/2024
1	Erectile Dysfunction 11/2023
1	Folliculitis (Sycosis) 04/2023
1	Exfoliative Dermatitis (Erythroderma) 02/2023
1	Lichen Sclerosus et Atrophicus (Lichen Sclerosus) 01/2023
1	Benign Familial Pemphigus (Hailey Hailey Disease) 11/2022
1	Hypersensitivity (Allergy) 09/2022

Drug/Important Bio-Agent (IBA)

8	dupilumabIBA 01/2024 - 01/2020
7	Imiquimod (Aldara)FDA LinkGeneric 12/2021 - 08/2005
6	tildrakizumabIBA 10/2023 - 01/2021
5	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2014
5	secukinumabIBA 02/2022 - 01/2019
4	Tacrolimus (Prograf)FDA LinkGeneric 04/2023 - 09/2011
4	brodalumabIBA 01/2023 - 05/2020
3	1-phenyl-3,3-dimethyltriazene (PDT)IBA 12/2023 - 01/2012
3	Monoclonal AntibodiesIBA 10/2023 - 02/2021
3	Adalimumab (Humira)FDA Link 01/2023 - 09/2021
3	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2022 - 01/2021
3	guselkumabIBA 01/2022 - 02/2021
3	Sunscreening Agents (Sunscreens)IBA 11/2020 - 06/2006
2	AllergensIBA 04/2024 - 09/2022
2	risankizumabIBA 01/2024 - 04/2022
2	upadacitinibIBA 12/2023 - 10/2021
2	apremilastIBA 12/2023 - 02/2022
2	SolutionsIBA 04/2023 - 01/2022
2	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2023 - 01/2023
2	dabrafenibIBA 01/2023 - 01/2016
2	Interleukin-23 (Interleukin 23)IBA 01/2023 - 02/2021
2	MART-1 AntigenIBA 03/2022 - 01/2022
2	ixekizumabIBA 01/2022 - 09/2021
2	Proteins (Proteins, Gene)FDA Link 11/2021 - 07/2005
2	sonidegibIBA 01/2021 - 01/2020
2	VemurafenibIBA 01/2016 - 05/2014
2	Polytetrafluoroethylene (Teflon)FDA Link 01/2013 - 10/2006
1	Long Noncoding RNAIBA 07/2024
1	serpentine (alkaloid)IBA 03/2024
1	Photosensitizing Agents (Photosensitizers)IBA 12/2023
1	Phosphodiesterase 5 InhibitorsIBA 11/2023
1	InterleukinsIBA 10/2023
1	Fluorouracil (Carac)FDA LinkGeneric 04/2023
1	Amitriptyline (Elavil)FDA LinkGeneric 01/2023
1	trametinibIBA 01/2023
1	Immune Checkpoint InhibitorsIBA 01/2023
1	NivolumabIBA 01/2023
1	Janus Kinase InhibitorsIBA 01/2023
1	Biocompatible Materials (Biomaterials)IBA 01/2023
1	pembrolizumabIBA 01/2023
1	Azathioprine (Imuran)FDA LinkGeneric 01/2023
1	tralokinumabIBA 01/2023
1	SuspensionsIBA 01/2023
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 11/2022
1	AdiponectinIBA 11/2022

Therapy/Procedure

29	Therapeutics 05/2024 - 09/2011
7	Biological Therapy 01/2024 - 01/2020
6	Immunotherapy 05/2024 - 01/2003
6	Radiotherapy 05/2024 - 01/2013
5	Photochemotherapy (Photodynamic Therapy) 12/2023 - 01/2012
3	Aftercare (After-Treatment) 02/2022 - 11/2019
3	Drug Therapy (Chemotherapy) 08/2020 - 01/2003
2	Operative Surgical Procedures 01/2024 - 09/2021
2	Mohs Surgery (Mohs' Micrographic Surgery) 08/2015 - 01/2013
2	Lasers (Laser) 05/2008 - 02/2004
1	Complementary Therapies (Alternative Medicine) 05/2024
1	Adjuvant Chemotherapy 01/2024
1	Adjuvant Radiotherapy 12/2023
1	Curettage 12/2023
1	Cryotherapy (Therapy, Cold) 04/2023
1	Organ Transplantation 11/2022